3-deoxy-1,2-O-isopropylidene-3-C-methyl-α-D-ribo-pentodialdo-1,4-furanose

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-deoxy-1,2-O-isopropylidene-3-C-methyl-α-D-ribo-pentodialdo-1,4-furanose
• 英文别名: (3aR,5S,6R,6aR)-2,2,6-trimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxole-5-carbaldehyde
• 化学式: C₉H₁₄O₄
• 分子量: 186.208
• InChiKey: FHMBRUZPSZDQAG-WCTZXXKLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-deoxy-1,2-O-isopropylidene-3-C-methyl-α-D-ribo-pentodialdo-1,4-furanose 在 sodium tetrahydroborate 、 溴 、 sodium hydride 、 potassium carbonate 、 barium benzoate 、 三氟乙酸 作用下， 以 1,4-二氧六环 、 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 生成 methyl (2S,3R,4S)-3-methyl-4-(phenylmethoxymethyl)oxetane-2-carboxylate
  参考文献：
  名称：

  Ring contraction of 3-deoxy-2-O-trifluoromethanesulphonates of α-hydroxy-γ-lactones to oxetanes

  摘要：

  DOI：

  10.1016/s0040-4039(00)97209-5
• 作为产物：
  描述：

  3-deoxy-1,2-O-isopropylidene-3-C-methyl-α-D-allofuranose 在 sodium periodate 作用下， 以 甲醇 为溶剂， 生成 3-deoxy-1,2-O-isopropylidene-3-C-methyl-α-D-ribo-pentodialdo-1,4-furanose
  参考文献：
  名称：

  Spirastrellolide B: The Synthesis of Southern (C₉−C₂₅) Region

  摘要：

  A combination of ''chiron" and "asymmetric" approaches is utilized to construct the southern (C-9-C-25) region of marine natural product spirastrellolide B. The key functionalities are derived from D-glucose and Sharpless asymmetric epoxidation and dihydroxylation.

  DOI：

  10.1021/ol801771s

文献信息

• SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
  申请人：Alios BioPharma, Inc.

  公开号：US20150105341A1

  公开（公告）日：2015-04-16

  Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a Picornavirus and/or Flaviviridae infection with one or more nucleosides, nucleotides and nucleotide analogs.

  本文披露了核苷、核苷酸和核苷酸类似物，以及它们的合成方法以及利用一个或多个核苷、核苷酸和核苷酸类似物治疗如小核糖核病毒和/或黄病毒科感染等疾病和/或症状的方法。
• 5' MODIFIED NUCLEOSIDES AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM
  申请人：Prakash Thazha P.

  公开号：US20130116420A1

  公开（公告）日：2013-05-09

  The present invention provides 5′ modified nucleosides and oligomeric compounds prepared therefrom. More particularly, the present invention provides modified nucleosides having at least one 5′-substituent and an optional 2′ substituent, oligomeric compounds comprising at least one of these modified nucleosides and methods of using the oligomeric compounds. In some embodiments, the oligomeric compounds provided herein are expected to hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.

  本发明提供了由其制备的5′修饰核苷和寡聚合物化合物。更具体地，本发明提供了至少具有一个5′-取代基和一个可选的2′取代基的修饰核苷，包括至少其中一种修饰核苷的寡聚合物化合物以及使用这些寡聚合物化合物的方法。在某些实施例中，本文提供的寡聚合物化合物预计将与目标RNA的部分杂交，导致目标RNA的正常功能丧失。
• D-AMINO ACID COMPOUNDS FOR LIVER DISEASE
  申请人：Idenix Pharmaceuticals LLC

  公开号：US20160002281A1

  公开（公告）日：2016-01-07

  Provided herein are compounds, compositions and methods for the treatment of liver disease and conditions, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.

  本文提供了用于治疗肝脏疾病和病状（包括HCV感染）的化合物、组合物和方法。在某些实施例中，披露了核苷衍生物的化合物和组合物，可以单独或与其他抗病毒药物联合使用。
• OLIGOMERIC COMPOUNDS AND METHODS
  申请人：Swayze Eric E.

  公开号：US20110313019A1

  公开（公告）日：2011-12-22

  The present invention provides oligomeric compounds and uses thereof. In certain embodiments, such oligomeric compounds are useful as antisense compounds. Certain such antisense compounds are useful as RNase H antisense compounds or as RNAi compounds.

  本发明提供了寡聚物化合物及其用途。在某些实施例中，这些寡聚物化合物可用作反义物质。某些这样的反义物质可用作RNase H反义物质或RNAi化合物。
• MODIFIED NUCLEOSIDES, ANALOGS THEREOF AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM
  申请人：Prakash Thazha P.

  公开号：US20130084576A1

  公开（公告）日：2013-04-04

  The present invention provides modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom. More particularly, the present invention provides modified nucleosides and analogs thereof that are useful for incorporation at the terminus of an oligomeric compound. Such oligomeric compounds can also be included in a double stranded composition. In some embodiments, the oligomeric compounds provided herein are expected to hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.

  本发明提供了改性核苷、其类似物和由其制备的寡核苷酸化合物。更具体地，本发明提供了可用于接入寡核苷酸化合物末端的改性核苷和其类似物。这样的寡核苷酸化合物也可以包含在双链组成物中。在某些实施例中，本文提供的寡核苷酸化合物预计会与目标RNA的一部分杂交，导致目标RNA的正常功能丧失。